Indeed, we demonstrated that adoptively transferred CD4+ T cells, through CD40L-CD40 interactions, license tumor-associated DCs to prime endogenous antitumor CD8+ T cells [24, 86]. The gene discussed is CD8A; the disease is neoplasm.